Viveve Medical, Inc. (VIVE) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerViveve Medical, Inc. (VIVE) trades at $0.0002. Viveve Medical, Inc. specializes in developing and marketing medical devices for women's health, focusing on non-invasive treatments for conditions like vaginal introital laxity. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for VIVE: VIVE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Viveve Medical, Inc. (VIVE) Healthcare & Pipeline Overview
Viveve Medical, Inc. focuses on women's health, developing and marketing the Viveve System, a non-invasive radiofrequency treatment for vaginal introital laxity and sexual function. With a global presence through sales employees and distributors, the company operates in a competitive medical device landscape, addressing a growing demand for women's health solutions.
What Is the Investment Thesis for VIVE?
Viveve Medical operates in the women's health medical device market, focusing on non-invasive treatments. While the company has a global presence, its financial performance, indicated by a negative profit margin of -342.8% and a negative P/E ratio, raises concerns. The company's growth hinges on the successful commercialization and adoption of the Viveve System, as well as potential expansion into new markets and indications. Investors may want to evaluate the competitive landscape and the company's ability to achieve profitability and sustainable growth.
Based on FMP financials and quantitative analysis
VIVE Key Highlights
Viveve Medical operates in the medical device industry, focusing on women's health.
- The company's core product is the Viveve System, a radiofrequency-based treatment for vaginal introital laxity.
- Viveve Medical has a global presence, marketing its products in the United States, Canada, Asia Pacific, Europe, the Middle East, and Latin America.
- The company's gross margin is 9.6%.
- Viveve Medical's profit margin is -342.8%.
Who Are VIVE's Competitors?
VIVE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 30 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.75 | +0.91% | $31.7M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.98 | +1.02% | $49.1M | 31 5-pillar |
| HYPD Hyperion DeFi, Inc. | $3.73 | +1.91% | $56.5M | 36 5-pillar |
| LNSR LENSAR, Inc. | $6.75 | +2.74% | $82.9M | 45 5-pillar |
| APYX Apyx Medical Corporation | $2.55 | +2.00% | $107M | 33 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VIVE's Key Strengths?
Proprietary radiofrequency technology
- Global distribution network
- Focus on non-invasive treatments
- Established brand in the women's health market
What Are VIVE's Weaknesses?
Negative profit margin
- Limited product portfolio
- Dependence on the Viveve System
- Small market capitalization
What Are the Key Risks for VIVE?
Financial-distress signal — its Altman Z-Score of -35.10 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 3 of the last 8 reported quarters.
- Competition from alternative treatments for vaginal laxity.
- Regulatory hurdles and delays in obtaining approvals for new products.
- Reimbursement challenges from insurance providers.
- Negative profit margin and financial losses.
What Are VIVE's Competitive Advantages?
- Patented Radiofrequency Technology: The Viveve System utilizes patented radiofrequency technology, providing a competitive advantage in the market for non-invasive vaginal rejuvenation treatments.
- Established Distribution Network: Viveve Medical has established a global distribution network, allowing it to reach customers in multiple countries and regions.
- Clinical Data and Efficacy: Clinical studies support the efficacy and safety of the Viveve System, providing a strong foundation for marketing and sales efforts.
What Does VIVE Do?
Founded in 2005 and headquartered in Englewood, Colorado, Viveve Medical, Inc. is a medical technology company dedicated to designing, developing, manufacturing, and marketing innovative medical devices for women's health. The company's primary focus is on non-invasive treatments for conditions such as vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve's flagship product, the Viveve System, utilizes patented radiofrequency technology to stimulate the body's natural collagen production process. The Viveve System comprises a radiofrequency generator, a reusable handpiece, and a disposable treatment tip, along with cryogen canisters and other consumable components. Viveve markets its products through a combination of direct sales employees and a network of distributors, reaching customers in the United States, Canada, the Asia Pacific region, Europe, the Middle East, and Latin America. The company continually seeks to expand its product offerings and geographic reach to address the evolving needs of women's health globally.
What Products and Services Does VIVE Offer?
- Designs medical devices for women's health.
- Develops non-invasive treatments for vaginal introital laxity.
- Manufactures the Viveve System, a radiofrequency-based treatment.
- Markets the Viveve System to healthcare providers.
- Offers solutions for sexual function and vaginal rejuvenation.
- Provides treatments for stress urinary incontinence.
How Does VIVE Make Money?
- Sells the Viveve System, including the radiofrequency generator and handpiece.
- Generates revenue from the sale of disposable treatment tips and cryogen canisters.
- Markets products through direct sales employees and distributors.
- Provides training and support to healthcare providers using the Viveve System.
What Industry Does VIVE Operate In?
Viveve Medical operates within the medical device industry, specifically targeting the women's health segment. This market is characterized by increasing demand for non-invasive and minimally invasive procedures. The competitive landscape includes companies offering alternative treatments for vaginal laxity and related conditions. Viveve's success depends on its ability to differentiate its technology, demonstrate clinical efficacy, and effectively market its products to healthcare providers and patients.
Who Are VIVE's Key Customers?
- Gynecologists and other women's health specialists.
- Medical spas and aesthetic clinics.
- Hospitals and outpatient surgical centers.
- Patients seeking non-invasive treatments for vaginal laxity and related conditions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Viveve Medical, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Englewood, US. VIVE has traded publicly since 1992.
Earnings Track Record
Viveve Medical, Inc. has missed Wall Street's EPS estimate in 3 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 3.1% below estimates on average.
Financial Health
Viveve Medical, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -35.10 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -85.0%, showing how much profit it generates from its asset base. A current ratio of 4.91 indicates the company holds enough short-term assets to cover its near-term obligations.
Insider Activity
12 transactions · 0 purchases, 0 sales, 12 other transactions · 6 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
VIVE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
VIVE Latest News
-
CCC® Build Sheets Delivers Measurable Improvements in Repair Accuracy and Efficiency
globenewswire.com · Sep 15, 2026
VIVE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for VIVE.
Price Targets
Wall Street price target analysis for VIVE.
VIVE MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for VIVE; grades run from A+ (80-100) to F (below 30).
Leadership: Martin Kerber
CEO
Martin Kerber serves as the CEO of Viveve Medical, Inc. His background includes experience in managing and leading teams within the medical device industry. He is responsible for overseeing the company's strategic direction, operations, and financial performance. His leadership is focused on driving growth and innovation within the organization.
Track Record: Under Martin Kerber's leadership, Viveve Medical has focused on expanding its market presence and advancing its product pipeline. He has overseen the company's efforts to commercialize the Viveve System and explore new applications for its radiofrequency technology. His strategic decisions aim to improve the company's financial performance and enhance shareholder value.
VIVE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Viveve Medical may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The availability of financial information for Viveve Medical may be limited due to its OTC listing.
- Lower Liquidity: Trading volume may be lower compared to stocks listed on major exchanges, potentially leading to wider bid-ask spreads.
- Regulatory Scrutiny: OTC-listed companies may face less regulatory oversight, increasing the risk of fraud or mismanagement.
- Delisting Risk: Viveve Medical could be delisted from the OTC market if it fails to meet certain requirements.
- Verify the company's financial statements and SEC filings.
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's stock trading volume and liquidity.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Established Business Operations: Viveve Medical has been in operation since 2005, indicating a level of business stability.
- Global Distribution Network: The company has a global distribution network, suggesting a broad market reach.
- Patented Technology: Viveve Medical's patented radiofrequency technology provides a competitive advantage.
- Focus on Women's Health: The company addresses a specific market need in the women's health sector.
VIVE Healthcare Stock FAQ
What does Viveve Medical, Inc. do?
Viveve Medical, Inc. is a medical technology company that designs, develops, manufactures, and markets medical devices for women's health. Its primary product is the Viveve System, which utilizes radiofrequency technology to provide non-invasive treatments for conditions such as vaginal introital laxity, sexual function, and stress urinary incontinence.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is based on the most recently available information.
- The analysis is based on publicly available information and management's statements.